한빛사 논문
Ju-Chan Parka,1, Jumee Kima,1, Hyun-Ki Jangb,f, Seung-Yeon Leea, Keun-Tae Kima, Eun-Ji Kwona, Seokwoo Parkc, Hyun Sik Leed, Hyewon Choie, Seung-Yeol Parke, Hee-Jung Choid, Soon-Jung Parkf, Sung-Hwan Moonf, Sangsu Baeb,g, Hyuk-Jin Chaa,*
aCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea
bInstitute for Convergence of Basic Sciences, Hanyang University, Seoul, Republic of Korea
cDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea
dDepartment of Biological Sciences, Seoul National University, Seoul, Republic of Korea
eDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea
fStem Cell Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea
gDepartment of Chemistry, Hanyang University, Seoul, Republic of Korea
1These authors contributed equally.
*Corresponding author.
Abstract
Despite the great potential of disease modeling using human pluripotent stem cells (hPSCs) derived from patients with mutations, lack of an appropriate isogenic control hinders a precise phenotypic comparison due to the bias arising from the dissimilar genetic backgrounds between the control and diseased hPSCs. Herein, we took advantage of currently available base editors (BEs) to epitomize the isogenic disease model from hPSCs. Using this method, we established multiple isogenic GNE myopathy disease models that harbor point mutations on the GNE gene, including four different mutations found in GNE myopathy patients. Four different mutations in the epimerase or kinase domains of GNE revealed mutation-specific hyposialylation, which was closely correlated to pathological clinical phenotypes. GNE protein structure modeling based on the mutations, addressed these mutation-specific hyposialylation patterns. Furthermore, treatment with a drug candidate currently under clinical trials showed a mutation-specific drug response in GNE myopathy disease models, showing hyposialylation dependent gene signature. These data suggest that derivation of multiple isogenic disease models from hPSCs by using genome editing can enable translationally relevant studies on the pathophysiology of GNE myopathy and drug responses.
Keywords : Genome editing, Base editor, Human pluripotent stem cells, Disease modeling, GNE myopathy, Hyposialylation, Isogenic pair, Myoblast
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기